BriaCell’s Clinical Data Accepted to be Presented at the Annual Symposium of Society of Surgical Oncology 2020 in Boston


You May Also Like

Sorrento Therapeutics Chairman/CEO update to stockholders

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Dear Sorrento ...

Paratek Pharmaceuticals Reports First Quarter 2018 Financial Results

-- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action ...